相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Elevated tauopathy and alpha-synuclein pathology in postmortem Parkinson's disease brains with and without dementia
Jonathan Wills et al.
EXPERIMENTAL NEUROLOGY (2010)
Evidence that glycogen synthase kinase-3 isoforms have distinct substrate preference in the brain
Marc P. M. Soutar et al.
JOURNAL OF NEUROCHEMISTRY (2010)
α-Synuclein contributes to GSK-3β-catalyzed Tau phosphorylation in Parkinson's disease models
Tetyana Duka et al.
FASEB JOURNAL (2009)
Regulated interactions of the norepineprhine transporter by the actin and microtubule cytoskeletons
Alexis M. Jeannotte et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Phosphorylation of tau and α-synuclein in synaptic-enriched fractions of the frontal cortex in Alzheimer's disease, and in Parkinson's disease and related α-synucleinopathies
G. Muntane et al.
NEUROSCIENCE (2008)
Site-specific effects of tau phosphorylation on its microtubule assembly activity and self-aggregation
Fei Liu et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2007)
Absence of ret signaling in mice causes progressive and late degeneration of the nigrostriatal system
Edgar R. Kramer et al.
PLOS BIOLOGY (2007)
Alpha-Synuclein induces hyperphosphorylation of Tau in the MPTP model of Parkinsonism
Tetyana Duka et al.
FASEB JOURNAL (2006)
Alzheimer's disease-like tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated tau transgenic mouse without any motor deficits
Katharina Schindowski et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
The neurotoxin, MPP+,, induces hyperphosphorylation of Tau, in the presence of α-synuclein, in SH-SY5Y neuroblastoma cells
Tetyana Duka et al.
NEUROTOXICITY RESEARCH (2006)
Interleukin-1 mediates Alzheimer and Lewy body pathologies
W. Sue T. Griffin et al.
JOURNAL OF NEUROINFLAMMATION (2006)
Highly potent and specific GSK-3β inhibitors that block Tau phosphorylation and decrease α-synuclein protein expression in a cellular model of Parkinson's disease
Alan P. Kozikowski et al.
CHEMMEDCHEM (2006)
GSK3B polymorphisms alter transcription and splicing in Parkinson's disease
JBJ Kwok et al.
ANNALS OF NEUROLOGY (2005)
The mitochondrial complex I inhibitor rotenone triggers a cerebral tauopathy
GU Höglinger et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Abundant neuritic inclusions and microvacuolar changes in a case of diffuse Lewy body disease with the A53T mutation in the α-synuclein gene
K Yamaguchi et al.
ACTA NEUROPATHOLOGICA (2005)
The role of α-synuclein gene multiplications in early-onset Parkinson's disease and dementia with Lewy bodies
A Hofer et al.
JOURNAL OF NEURAL TRANSMISSION (2005)
Role of oxidative stress in paraquat-induced dopaminergic cell degeneration
AL McCormack et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Striatal expression of GDNF and differential vulnerability of midbrain dopaminergic cells
P Barroso-Chinea et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2005)
Tau phosphorylation increases in symptomatic mice overexpressing A30P α-synuclein
M Frasier et al.
EXPERIMENTAL NEUROLOGY (2005)
Tyrosine-to-cysteine modification of human α-synuclein enhances protein aggregation and cellular toxicity
WB Zhou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Lewy body-related α-synucleinopathy in the aged human brain
KA Jellinger
JOURNAL OF NEURAL TRANSMISSION (2004)
Tau becomes a more favorable substrate for GSK-3 when it is prephosphorylated by PKA in rat brain
SJ Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Fibrillization of α-synuclein and tau in familial Parkinson's disease caused by the A53T α-synuclein mutation
PT Kotzbauer et al.
EXPERIMENTAL NEUROLOGY (2004)
Tau pathology in the olfactory bulb correlates with Braak stage, Lewy body pathology and apolipoprotein ε4
Y Tsuboi et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2003)
Colocalization of tau and alpha-synuclein epitopes in Lewy bodies
T Ishizawa et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2003)
Loss of response to levodopa in Parkinson's disease and co-occurrence with dementia:: role of D3 and not D2 receptors
JN Joyce et al.
BRAIN RESEARCH (2002)
Concurrence of α-synuclein and tau brain pathology in the Contursi kindred
JE Duda et al.
ACTA NEUROPATHOLOGICA (2002)
Neuronal α-synucleinopathy with severe movement disorder in mice expressing A53T human α-synuclein
BI Giasson et al.
NEURON (2002)
Tau and α-synuclein pathology in amygdala of parkinsonism-dementia complex patients of Guam
MS Forman et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
α-Synuclein-positive structures in cases with sporadic Alzheimer's disease:: morphology and its relationship to tau aggregation
Y Arai et al.
BRAIN RESEARCH (2001)
α-synuclein inclusions in amygdala in the brains of patients with the Parkinsonism-dementia complex of Guam
M Yamazaki et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2000)
Conformational change as one of the earliest alterations of tan in Alzheimer's disease
CL Weaver et al.
NEUROBIOLOGY OF AGING (2000)
分享论文
